Yes, aspirin is an anti-inflammatory drug. It belongs to the nonsteroidal anti-inflammatory drug (NSAID) class, sitting alongside ibuprofen and naproxen. But aspirin is unique among NSAIDs in several ways, and the dose you take determines whether you’re getting meaningful anti-inflammatory effects or primarily other benefits like pain relief or blood-clot prevention.
How Aspirin Reduces Inflammation
Your body produces compounds called prostaglandins that trigger inflammation, pain, and fever. Two enzymes, COX-1 and COX-2, are responsible for making these prostaglandins. Aspirin works by permanently disabling both enzymes. It physically attaches to a specific spot in each enzyme’s active site, blocking the raw material (arachidonic acid) from being processed. This is an irreversible change: once aspirin modifies a COX enzyme, that enzyme is shut down for good. The cell has to build an entirely new one.
This irreversibility is what makes aspirin different from ibuprofen or naproxen, which temporarily block the same enzymes and then let go. It’s also why a single low dose of aspirin can suppress blood clotting for roughly 10 days, the full lifespan of a platelet, since platelets can’t manufacture replacement enzymes. At higher doses, the same permanent shutdown of COX-1 and COX-2 throughout the body produces the anti-inflammatory and fever-reducing effects aspirin is known for.
Dose Determines the Effect
Aspirin does three things: prevents blood clots, relieves pain, and reduces inflammation. But each effect kicks in at a different dose range.
- Anti-platelet (blood clot prevention): 75 to 100 mg per day. This is the familiar “baby aspirin” or low-dose aspirin. It’s enough to shut down clot-promoting activity in platelets but too low to have a real anti-inflammatory impact.
- Pain relief (analgesic): 500 to 1,000 mg per dose. Standard over-the-counter aspirin tablets fall in this range. At these doses, aspirin provides moderate pain relief comparable to ibuprofen, though head-to-head data show ibuprofen at equivalent doses tends to help a slightly higher percentage of people achieve meaningful relief.
- Anti-inflammatory: Sustained high doses, often 3,000 mg per day or more for conditions like rheumatic fever. These doses are only used under medical supervision because the risk of side effects climbs steeply.
In clinical pain studies, doubling the aspirin dose from around 500 to 1,000 mg increased the number of people getting at least 50% pain relief from about 40% to 47%. The dose-response curve is not steep, meaning you get diminishing returns as you increase the amount. This is one reason other NSAIDs have largely replaced aspirin for treating inflammation in everyday use.
How Aspirin Compares to Other NSAIDs
While aspirin is technically in the same drug class as ibuprofen and naproxen, it’s rarely the first choice for treating inflammation today. In head-to-head analgesic trials, 800 mg of ibuprofen provided at least 50% pain relief in 79% of patients, while 1,200 mg of aspirin achieved the same threshold in 61%. At lower doses (600 to 650 mg), aspirin’s success rate dropped to 38%.
Naproxen offers a practical advantage for chronic inflammatory conditions because of its long half-life, allowing once- or twice-daily dosing. Aspirin’s plasma half-life is just 20 minutes, so its direct chemical presence in the blood is fleeting. The anti-platelet effect persists for days because of that irreversible enzyme shutdown, but for ongoing inflammation, you’d need to take aspirin multiple times a day at high doses. Ibuprofen and naproxen achieve comparable or better anti-inflammatory results with fewer required doses and a generally more favorable side-effect profile at those levels.
Where High-Dose Aspirin Is Still Used
Despite being mostly replaced by other NSAIDs for common aches and swelling, aspirin remains a standard treatment for specific inflammatory conditions. Acute rheumatic fever is the clearest example. Patients with this condition are started on aspirin at 50 to 60 mg per kilogram of body weight per day, divided into four or five doses. That dose can be increased if symptoms don’t improve, then gradually tapered over one to two weeks after symptoms resolve. The previous standard of 80 to 100 mg/kg/day was lowered because of toxicity concerns, including stomach irritation and ringing in the ears (tinnitus).
Kawasaki disease in children is another exception where aspirin is used despite the general rule against giving it to kids. In these specific cases, the anti-inflammatory benefit outweighs the risks under close medical supervision.
Stomach and Bleeding Risks
All NSAIDs can irritate the stomach lining, but aspirin’s irreversible COX-1 inhibition makes this a particular concern at anti-inflammatory doses. COX-1 helps maintain the protective mucus layer in your stomach, so disabling it leaves the lining more vulnerable to acid damage.
A large randomized trial of over 19,000 older adults (the ASPREE trial) found that even low-dose aspirin increased the overall risk of serious gastrointestinal bleeding by 60% compared to placebo. The upper GI tract was hit hardest, with nearly twice as many bleeds in the aspirin group. For a healthy 70-year-old not taking aspirin, the absolute five-year risk of a major GI bleed was about 0.25%. For an 80-year-old on aspirin with additional risk factors, that number climbed to around 5%. These numbers come from low-dose use. At the high doses needed for anti-inflammatory effects, the risk is substantially greater, which is why anti-inflammatory doses of aspirin (around 3,900 mg per day in one trial) were studied alongside stomach-protecting medications to reduce mucosal injury.
Low-Dose Aspirin for Heart Health
Most people taking aspirin daily are using it at low doses for cardiovascular protection, not inflammation. At 81 mg per day (the most common U.S. dose), aspirin prevents platelets from clumping and forming dangerous clots. This is a completely different use from its anti-inflammatory function, even though the same enzyme-blocking mechanism is involved.
Current guidelines from the U.S. Preventive Services Task Force are more cautious than they used to be. For adults 40 to 59 with at least a 10% ten-year risk of cardiovascular disease, low-dose aspirin is an individual decision, not a blanket recommendation. The net benefit is considered small and works best for people who aren’t at increased bleeding risk. For adults 60 and older, the task force recommends against starting aspirin for primary heart disease prevention altogether, because the bleeding risks tend to outweigh the cardiovascular benefits at that age. For people already taking aspirin for a confirmed heart condition, stopping is a separate conversation with their doctor.
Aspirin and Children
Aspirin should not be given to children or teenagers for fever or pain. It has been linked to Reye’s syndrome, a rare but serious condition affecting the brain and liver, particularly when taken during viral illnesses like the flu or chickenpox. Acetaminophen and ibuprofen are the recommended alternatives for kids. The only exceptions are specific conditions like Kawasaki disease, where aspirin is prescribed and monitored by a physician.